Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Active, not recruiting

Conditions: Brain Tumor
Pediatric Cancer
Pediatric Brain Tumor

Interventions: Diagnostic Test: Diffusion tensor imaging (DTI)
Diagnostic Test: Resting state functional connectivity MRI (rs-fcMRI)
Behavioral: Wechsler Intelligence Scale for Children - 5th edition (WISC-V)
Behavioral: California Verbal Learning Test (CVLT-C)
Behavioral: Beery Test of Visual Motor Integration 6th edition
Behavioral: PedsQL Multidimensional Fatigue Scale
Behavioral: Grooved Pegboard
Diagnostic Test: MRI

First Posted Date: 2017-07-05

Last Posted Date: 2024-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT03208387

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

and more 1 locations

Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling

Active, not recruiting

Conditions: Carcinoma
Cancer

Interventions: Behavioral: Prior Exercise Behavior Questions - Harvard Health Professionals Exercise Questionnaire

First Posted Date: 2017-07-05

Last Posted Date: 2024-08-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1600

Registration Number: NCT03208374

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only), Montvale, New Jersey, United States

and more 4 locations

PSMA PET Imaging of Recurrent Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Adenocarcinoma
Prostate Cancer

Interventions: Drug: Ga-HBED-iPSMA PET
Diagnostic Test: PET/CT
Diagnostic Test: MRI

First Posted Date: 2017-06-29

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1171

Registration Number: NCT03204123

Locations: 🇺🇸
Memorial Sloan Kettering Nassau (Consent only), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey, United States

and more 4 locations

A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma

Phase 1

Withdrawn

Conditions: Solitary Bone Plasmacytoma

Interventions: Drug: Durvalumab
Radiation: Radiation therapy

First Posted Date: 2017-06-22

Last Posted Date: 2018-08-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT03196401

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memoral Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 3 locations

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

Not Applicable

Active, not recruiting

Conditions: Thyroid Cancer

Interventions: Procedure: PET Imaging
Other: 18F-tetrafluoroborate (18F-TFB)

First Posted Date: 2017-06-22

Last Posted Date: 2025-06-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 5

Registration Number: NCT03196518

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Chemoimmunotherapy for High-Risk Neuroblastoma

Early Phase 1

Active, not recruiting

Conditions: Neuroblastoma (NB)

Interventions: Drug: Irinotecan
Drug: temozolomide
Biological: Hu3F8
Drug: GM-CSF

First Posted Date: 2017-06-16

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 48

Registration Number: NCT03189706

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Acupuncture for Symptoms of Nerve Damage

Not Applicable

Completed

Conditions: Chemotherapy-induced Peripheral Neuropathy
Peripheral Neuropathy

Interventions: Procedure: Acupuncture
Procedure: Sham Acupuncture
Other: Usual Care Group
Behavioral: questionnaires

First Posted Date: 2017-06-09

Last Posted Date: 2024-05-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 75

Registration Number: NCT03183037

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas

Phase 2

Active, not recruiting

Conditions: Lymphoma
Relapsed
Refractory

Interventions: Drug: Entinostat
Drug: Pembrolizumab

First Posted Date: 2017-06-07

Last Posted Date: 2025-01-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 47

Registration Number: NCT03179930

Locations: 🇺🇸
Roswell Park Cancer Institute (Data Collection Only), Buffalo, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 6 locations

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

Phase 2

Active, not recruiting

Conditions: Hodgkin Lymphoma

Interventions: Drug: Pembrolizumab
Radiation: Involved Site Radiation Therapy

First Posted Date: 2017-06-07

Last Posted Date: 2025-05-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT03179917

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 6 locations

Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients

Completed

Conditions: Patient Reported Outcomes

Interventions: Other: Team Monitoring
Other: Enhanced Feedback

First Posted Date: 2017-06-06

Last Posted Date: 2023-06-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2793

Registration Number: NCT03178045

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

AI-Powered Research

Premium Access

Memorial Sloan Kettering Cancer Center

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling

PSMA PET Imaging of Recurrent Prostate Cancer

A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

Study of Chemoimmunotherapy for High-Risk Neuroblastoma

Acupuncture for Symptoms of Nerve Damage

Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients